Risk Factors for Severe COVID-19 and Hepatitis C Infections: The Dual Role of Apolipoprotein E4

Front Immunol. 2022 Mar 11:13:721793. doi: 10.3389/fimmu.2022.721793. eCollection 2022.

Authors

Felipe B Lima^{1

2}, Karine C Bezerra¹, José Carlos R Nascimento^{1

2}, Gdayllon C Meneses³, Reinaldo B Oriá¹

Affiliations

¹ Laboratory of Tissue Healing, Ontogeny and Nutrition, Department of Morphology, School of Medicine, Institute of Biomedicine, Federal University of Ceara, Fortaleza, Brazil.
² Division of Anesthesiology, Hospital Geral de Fortaleza, Fortaleza, Brazil.
³ Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil.

No abstract available

Keywords: COVID-19; apolipoprotein E4; hepatitis C (HCV) infection; inflammation; liver.

MeSH terms

Apolipoprotein E4 / genetics
COVID-19*
Hepacivirus
Hepatitis C*
Humans
Risk Factors

Substances

Apolipoprotein E4